Literature DB >> 27890530

Provider Perspectives on Adding Biomarker Screening for Tobacco Smoke Exposure to Lead Screening at Well-Child Visits.

Winta Ghidei, Gail Brottman, Eline Lenne, Tukhanh Quan, Anne Joseph.   

Abstract

INTRODUCTION: Measurement of cotinine, a biomarker of tobacco smoke exposure, can accurately identify children at risk of health consequences from secondhand smoke. This study reports perspectives from pediatric health care providers on incorporating routine cotinine screening into well-child visits.
METHODS: Key informant interviews (N = 28) were conducted with pediatric primary care providers: physicians, nurse practitioners, and registered nurses.
RESULTS: Themes identified in the interviews included the following: (a) Cotinine screening would assess children's exposure to tobacco smoke more reliably than parental report; (b) Addressing positive cotinine screening results might require additional resources; (c) Wheezing and a history of emergency department visits increased the salience of cotinine screening; and (d) A better understanding of the significance of specific cotinine test values would improve utility. DISCUSSION: Pediatric providers see advantages of biomarker screening for tobacco smoke exposure at well-child visits, especially for children with wheezing, but have concerns about limited capacity for follow-up with parents.
Copyright © 2016 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cotinine; pediatric primary care; pediatric well-child visit; secondhand smoke; tobacco smoke exposure reduction

Mesh:

Substances:

Year:  2016        PMID: 27890530     DOI: 10.1016/j.pedhc.2016.10.007

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  1 in total

1.  Ask about smoking, not quitting: a chronic disease approach to assessing and treating tobacco use.

Authors:  Steven L Bernstein; Benjamin A Toll
Journal:  Addict Sci Clin Pract       Date:  2019-09-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.